Poly (alkylcyanoacrylates) as biodegradable materials for biomedical applications

C Vauthier, C Dubernet, E Fattal… - Advanced drug delivery …, 2003 - Elsevier
This review considers the use of poly (alkylcyanoacrylates)(PACAs) as biomedical materials.
We first present the different aspects of the polymerization of alkylcyanoacrylate monomers …

Synthesis of poly (alkyl cyanoacrylate)‐based colloidal nanomedicines

J Nicolas, P Couvreur - Wiley Interdisciplinary Reviews …, 2009 - Wiley Online Library
Nanoparticles developed from poly (alkyl cyanoacrylate)(PACA) biodegradable polymers
have opened new and exciting perspectives in the field of drug delivery due to their nearly …

[图书][B] Introduction to nanoscience and nanotechnology

GL Hornyak, HF Tibbals, J Dutta, JJ Moore - 2008 - api.taylorfrancis.com
The maturation of nanotechnology has revealed it to be a unique and distinct discipline
rather than a specialization within a larger field. Its textbook cannot afford to be a chemistry …

Comparison of scanning electron microscopy, dynamic light scattering and analytical ultracentrifugation for the sizing of poly (butyl cyanoacrylate) nanoparticles

A Bootz, V Vogel, D Schubert, J Kreuter - European journal of …, 2004 - Elsevier
Nanoparticles represent promising carriers for controlled drug delivery. This work focuses on
the size and molecular mass characterization of polyalkylcyanoacrylate nanoparticles …

Chemotherapy of brain tumour using doxorubicin bound to surfactant-coated poly (butyl cyanoacrylate) nanoparticles: revisiting the role of surfactants

B Petri, A Bootz, A Khalansky, T Hekmatara… - Journal of Controlled …, 2007 - Elsevier
Poly (butyl cyanoacrylate) nanoparticles coated with poloxamer 188 (Pluronic® F68) and
also, as shown previously, polysorbate 80 (Tween® 80) considerably enhance the anti …

[图书][B] Pharmaceutical dosage forms: Disperse systems

H Lieberman, M Rieger, GS Banker - 2020 - books.google.com
Stressing the theory involved in formulating suspensions, emulsions, and colloidal drug
products, this Second Edition of a well-received reference test highlights typical …

Increase of the duration of the anticonvulsive activity of a novel NMDA receptor antagonist using poly (butylcyanoacrylate) nanoparticles as a parenteral controlled …

A Friese, E Seiller, G Quack, B Lorenz… - European journal of …, 2000 - Elsevier
A novel non-competitive NMDA receptor antagonist MRZ 2/576 is a potent but rather short-
acting (5–15 min) anticonvulsant following intravenous administration to mice as estimated …

Influence of surfactants, polymer and doxorubicin loading on the anti-tumour effect of poly (butyl cyanoacrylate) nanoparticles in a rat glioma model

A Ambruosi, S Gelperina, A Khalansky… - Journal of …, 2006 - Taylor & Francis
Poly (n-butyl cyanoacrylate) nanoparticles coated with polysorbate-80 can enable the
transport of bound drugs across the blood–brain barrier (BBB) after iv injection. In the …

Development of polymer microcapsules functionalized with fucoidan to target P‐selectin overexpressed in cardiovascular diseases

B Li, M Juenet, R Aid‐Launais, M Maire… - Advanced …, 2017 - Wiley Online Library
New tools for molecular imaging and targeted therapy for cardiovascular diseases are still
required. Herein, biodegradable microcapsules (MCs) made of polycyanoacrylate and …

Poly (n-butyl cyanoacrylate) nanoparticles via miniemulsion polymerization (1): Dextran-based surfactants

M Wu, E Dellacherie, A Durand, E Marie - Colloids and surfaces B …, 2009 - Elsevier
This study aims at synthesizing polysaccharide-coated poly (n-butyl cyanoacrylate)
nanoparticles by miniemulsion polymerization. Because of the high reactivity of n-butyl …